As of 2025-08-06, the Intrinsic Value of Dyne Therapeutics Inc (DYN) is -14.97 USD. This DYN valuation is based on the model Peter Lynch Fair Value. With the current market price of 10.47 USD, the upside of Dyne Therapeutics Inc is -243.00%.
Based on its market price of 10.47 USD and our intrinsic valuation, Dyne Therapeutics Inc (DYN) is overvalued by 243.00%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -14.97 - -14.97 | -14.97 | -243.00% |
| P/E | (42.52) - (81.45) | (64.08) | -712.1% |
| DDM - Stable | (22.94) - (69.11) | (46.02) | -539.6% |
| DDM - Multi | (2.24) - (5.26) | (3.14) | -130.0% |
| Market Cap (mil) | 1,443.60 |
| Beta | 2.05 |
| Outstanding shares (mil) | 137.88 |
| Enterprise Value (mil) | 1,057.38 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.52% |
| Cost of Debt | 5.00% |
| WACC | 7.09% |